A novel CDK4/6 inhibitor,palbociclib
FAN Li-ping;JIAO Yuan-yuan;GUO Zi-han;ZHANG Yan-hua;Key Laboratory of Carcinogenesis and Translational Research;Department of Pharmacy;Peking University Cancer Hospital & Institute;Department of Pharmacy Administration and Clinical Pharmacy;School of Pharmaceutical Sciences;Peking University Health Science Center;
..............page:2161-2163+2202
..............page:2164-2166+2226
..............page:2167-2174
..............page:2175-2178
..............page:2179-2182
..............page:2183-2187+2250
..............page:2188-2190+2196
..............page:2191-2196
..............page:2197-2202
..............page:2203-2208
..............page:2209-2213
..............page:2214-2217
..............page:2218-2221+2256
..............page:2222-2226
..............page:2227-2230
..............page:2231-2234
..............page:2235-2240
..............page:2241-2244+2265
..............page:2245-2250
..............page:2251-2256
..............page:2257-2265
..............page:2266-2270
Analysis of the constitution of anti-glaucoma drugs in medical institutions
LIN Qi-min;HAN Sheng;WANG Ji-bin;GUAN Xiao-dong;MA Man-ling;WANG Chang-lian;HOU Rui-gang;SHI Lu-wen;Peking University School of Pharmaceutical Sciences;International Research Center of Medicinal Administration;Development Center of Science and Technology of Chinese Pharmaceutical Association;Pharmacy Department of The First Affiliated Hospital of Haerbin Medical University;Pharmacy Department of The First Affiliated Hospital of Fujian Medical University;Pharmacy Department of The Second Hospital of Shanxi Medical University;
..............page:2271-2276
..............page:2277-2280